关注
Tejashri Chavan
Tejashri Chavan
Kenox Pharmaceuticals
在 stjohns.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Repurposing bedaquiline for effective non-small cell lung cancer (NSCLC) therapy as inhalable cyclodextrin-based molecular inclusion complexes
V Parvathaneni, RS Elbatanony, M Goyal, T Chavan, N Vega, S Kolluru, ...
International journal of molecular sciences 22 (9), 4783, 2021
282021
The diverse bioactivity of α-mangostin and its therapeutic implications
T Chavan, A Muth
Future Medicinal Chemistry 13 (19), 1679-1694, 2021
202021
Effect of spray drying on amorphization of indomethacin nicotinamide cocrystals; optimization, characterization, and stability study
HM Tawfeek, T Chavan, NK Kunda
AAPS PharmSciTech 21, 1-13, 2020
142020
Solubility enhancement and inhalation delivery of cyclodextrin-based inclusion complex of delamanid for pulmonary tuberculosis treatment
SM Patil, DS Barji, T Chavan, K Patel, AJ Collazo, V Prithipaul, A Muth, ...
AAPS PharmSciTech 24 (1), 49, 2023
102023
Small-molecule Gankyrin inhibition as a therapeutic strategy for breast and lung cancer
D Kanabar, M Goyal, EI Kane, T Chavan, A Kabir, X Wang, S Shukla, ...
Journal of medicinal chemistry 65 (13), 8975-8997, 2022
82022
Introduction to nanomedicine in drug delivery
T Chavan, P Muttil, NK Kunda
Mucosal Delivery of Drugs and Biologics in Nanoparticles, 3-26, 2020
62020
Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment
M Goyal, G Tulsyan, DD Kanabar, T Chavan, A Muth, V Gupta
Journal of Drug Delivery Science and Technology 87, 104767, 2023
52023
Identification of novel gankyrin binding scaffolds by high throughput virtual screening.
D Kanabar, A Kabir, T Chavan, J Kong, S Yoganathan, A Muth
Bioorganic & Medicinal Chemistry Letters 43, 128043-128043, 2021
32021
Structural modification of the propyl linker of cjoc42 in combination with sulfonate ester and triazole replacements for enhanced gankyrin binding and anti-proliferative activity
T Chavan, D Kanabar, K Patel, TM Laflamme, M Riyazi, DE Spratt, A Muth
Bioorganic & Medicinal Chemistry 110, 117836, 2024
2024
Synthesis and evaluation of 2, 5-substituted pyrimidines as small-molecule gankyrin binders
D Kanabar, EI Kane, T Chavan, TM Laflamme, E Suarez, M Goyal, ...
Future Medicinal Chemistry 16 (3), 239-251, 2024
2024
Targeting the Oncoprotein Gankyrin with Small Molecules to Alter its 3D Global Fold
M Riyazi, T Laflamme, E Kane, D Kanabar, T Chavan, A Muth, DE Spratt
PROTEIN SCIENCE 32 (12), 2023
2023
Specificity studies of small molecule inhibitors targeting the ankyrin-repeat oncoprotein gankyrin
T Laflamme, E Kane, DE Spratt, A Muth, D Kanabar, T Chavan
PROTEIN SCIENCE 32 (12), 2023
2023
Structural Modification of the Propyl Linker of Cjoc42 for Enhanced Gankyrin Binding and Anti-cancer Activity
T Chavan
2022
Development of conformationally constrained cjoc42 derivatives for binding gankyrin
T Chavan, A Muth
American Chemical Society SciMeetings 1 (1), 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–14